GlaxoSmithKline Pharmaceuticals Ltd has announced that the Company has completed its transaction with Novartis Healthcare on September 30, 2015 whereby the Company has acquired Novartis’ vaccines business and divested its marketed oncology portfolio to Novartis India.
| Subscribe To Our Free Newsletter |
